ClinicalTrials.Veeva

Menu

Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients

T

Tanta University

Status and phase

Unknown
Phase 3

Conditions

Liver Cirrhosis

Treatments

Drug: Calcium Carbonate
Drug: Methocarbamol

Study type

Interventional

Funder types

Other

Identifiers

NCT02642874
methocarbamol

Details and patient eligibility

About

Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.

Full description

Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Abrams et al compared patients with cirrhosis with those with congestive heart failure and found a significantly higher prevalence of weekly or daily cramps with cirrhosis (22%) vs patients with congestive heart failure (5%). Interestingly, there was no difference in diuretic use or dosing between the 2 groups, supporting that factors other than diuretic-mediated effects explained the differences. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Cirrhotic patients with frequent muscle cramps.

Exclusion criteria

  • Elderly patients.
  • Encephalopathy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 2 patient groups, including a placebo group

Methocarbamol
Experimental group
Description:
Methocarbamol twice daily
Treatment:
Drug: Methocarbamol
placebo
Placebo Comparator group
Description:
Calcium carbonate twice daily
Treatment:
Drug: Calcium Carbonate

Trial contacts and locations

1

Loading...

Central trial contact

Sherief M. Abd-Elsalam, Consultant

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems